Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Qol and Patients' Care

Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP

Bone Marrow Transplantation volume 50, pages 592–597 (2015)Cite this article

Subjects

Abstract

The aim of this analysis was to explore the diversity of reduced intensity conditioning (RIC) in paediatric allo-SCT in daily practice across Europe. Data from the European Group for Blood and Marrow Transplantation (EBMT) Promise database from 1994 to 2008 were supplemented by a survey of EBMT centres performing paediatric allo-SCT on the current policy asking for the underlying diseases and for the drug combinations. Records from 161 centres from 30 countries were analysed and 139 various RIC regimens were reported. More centres applied RIC for malignant rather than for non-malignant diseases. In general, fludarabine (FLU)-based regimens predominated except for BU-based regimens in myeloid malignancies and haemoglobinopathies. Treosulfan (TREO) was mainly applied for unspecified malignant diseases and for haemophagocytic diseases. FLU-based regimens revealed the greatest number of different combinations. Correlating the number of regimens with the number of treating centres revealed the lowest variety in FLU and the highest variety in TBI and TREO. FLU/melphalane and FLU/CY were the most frequent combinations. This extreme heterogeneity in RIC may influence both the efficacy and the safety of the procedures, which requires further investigation. Optimization and standardization of RIC is the final goal to provide a platform for future prospective studies.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Satwani P, Cooper N, Rao K, Veys P, Amrolia P . Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases. Bone Marrow Transplant 2008; 41: 173–182.

    Article  CAS  PubMed  Google Scholar 

  2. Del Toro G, Satwani P, Harrison L, Cheung YK, Brigid Bradley M, George D et al. A pilot study of reduced intensity conditioning and allogeneic stem cell transplantation from unrelated cord blood and matched family donors in children and adolescent recipients. Bone Marrow Transplant 2004; 33: 613–622.

    Article  CAS  PubMed  Google Scholar 

  3. Gomez-Almaguer D, Ruiz-Arguelles GJ, Tarin-Arzaga Ldel C, Gonzalez-Llano O, Jaime-Perez JC, Lopez-Martinez B et al. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience. Biol Blood Marrow Transplant 2003; 9: 157–161.

    Article  PubMed  Google Scholar 

  4. Duerst R, Jacobsohn D, Tse WT, Kletzel M . Efficacy of reduced intensity conditioning (RIC) with FLU-BU-ATG and allogeneic hematopoietic stem cell transplantation (HSCT) for pediatric ALL. ASH Annual Meeting Abstracts 2004; 104: 2314.

    Google Scholar 

  5. Roman E, Cooney E, Harrison L, Militano O, Wolownik K, Hawks R et al. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia. Clin Cancer Res 2005; 11: 7164 s–7170 s.

    Article  Google Scholar 

  6. Claviez A, Klingebiel T, Beyer J, Nurnberger W, Ehninger G, Suttorp M et al. Allogeneic peripheral blood stem cell transplantation following fludarabine-based conditioning in six children with advanced Hodgkin's disease. Ann Hematol 2004; 83: 237–241.

    Article  PubMed  Google Scholar 

  7. Nagler A, Labopin M, Shimoni A, Volin L, Bunjes DW, Huynh A et al. Comparison of outcomes after allogeneic HSCT for adult patients with AML in remission using in the conditioning regimen either I.V. Busulfex (BU) Plus Cyclophosphamide (Cy) or TBI Plus Cy: An- ALWP-EBMT Survey. ASH Annual Meeting Abstracts 2009; 114: 195.

    Google Scholar 

  8. Pulsipher MA, Boucher KM, Wall D, Frangoul H, Duval M, Goyal RK et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009; 114: 1429–1436.

    Article  CAS  PubMed  Google Scholar 

  9. Veys P, Rao K, Amrolia P . Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning. Bone Marrow Tansplant 2005; 35: S45–S47.

    Article  Google Scholar 

  10. Yaniv I, Stein J, Party EPW . Reduced-intensity conditioning in children: a reappraisal in 2008. Bone Marrow Transplant 2008; 41: S18–S22.

    Article  PubMed  Google Scholar 

  11. Strahm B, Locatelli F, Bader P, Ehlert K, Kremens B, Zintl F et al. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood. Bone Marrow Transplant 2007; 40: 329–333.

    Article  CAS  PubMed  Google Scholar 

  12. Champlin R, Khouri I, Komblau S, Molidrem J, Giralt S . Reinventing bone marrow transplantation. Nonmyeloablative preparative regimens and induction of graft-vs-malignancy effect. Oncology 1999; 13: 621–628 discussion 631, 635–638, 641.

    CAS  PubMed  Google Scholar 

  13. Bacigalupo A . Hematopoietic stem cell transplants after reduced intensity conditioning regimen (RI-HSCT): report of a workshop of the European group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 2000; 25: 803–805.

    Article  CAS  PubMed  Google Scholar 

  14. Bacigalupo A . Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT). Bone Marrow Transplant 2002; 29: 191–195.

    Article  CAS  PubMed  Google Scholar 

  15. Bacigalupo A . Third EBMT/AMGEN Workshop on reduced-intensity conditioning allogeneic haemopoietic stem cell transplants (RIC-HSCT), and panel consensus. Bone Marrow Transplant 2004; 33: 691–696.

    Article  CAS  PubMed  Google Scholar 

  16. Bacigalupo A, Ballen K, Rizzo D, Giralt S, Lazarus H, Ho V et al. Defining the intensity of conditioning regimens: working definitions. Biol Blood Marrow Transplant 2009; 15: 1628–1633.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Giralt S, Ballen K, Rizzo D, Bacigalupo A, Horowitz M, Pasquini M et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant 2009; 15: 367–369.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Apperley J CE, Gluckman E, Masszi T . Principles of conditioning. The EBMT Handbook Haemopoietic Stem Cell Transplantation, 6th edn. European School of Haematology, 2012.

    Google Scholar 

  19. Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A . European Group for Blood and Marrow Transplantation (EBMT). Accreditation Committee.. Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey. Bone Marrow Transplant 2002; 30: 813–831.

    Article  CAS  PubMed  Google Scholar 

  20. Stein J, Dini G, Yaniv I . Pediatric Diseases Working Party of the EBMT. The hope and the reality of reduced intensity transplants in children with malignant diseases. Bone Marrow Transplant 2005; 35: S39–S43.

    Article  PubMed  Google Scholar 

  21. Strullu M, Rialland F, Cahu X, Brissot E, Corradini N, Thomas C et al. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience. Eur J Haematol 2012; 88: 504–509.

    Article  CAS  PubMed  Google Scholar 

  22. Luger SM, Ringden O, Zhang MJ, Perez WS, Bishop MR, Bornhauser M et al. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS. Bone Marrow Transplant 2012; 47: 203–211.

    Article  CAS  PubMed  Google Scholar 

  23. Rao K, Amrolia PJ, Jones A, Cale CM, Naik P, King D et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005; 105: 879–885.

    Article  CAS  PubMed  Google Scholar 

  24. Burroughs LM, Storb R, Leisenring WM, Pulsipher MA, Loken MR, Torgerson TR et al. Intensive postgrafting immune suppression combined with nonmyeloablative conditioning for transplantation of HLA-identical hematopoietic cell grafts: results of a pilot study for treatment of primary immunodeficiency disorders. Bone Marrow Transplant 2007; 40: 633–642.

    Article  CAS  PubMed  Google Scholar 

  25. Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S et al. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood 2011; 117: 4367–4375.

    Article  CAS  PubMed  Google Scholar 

  26. Bartelink IH, van Reij EM, Gerhardt CE, van Maarseveen EM, de Wildt A, Versluys B et al. Fludarabine and exposure-targeted busulfan compares favorably with busulfan/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity. Biol Blood Marrow Transplant 2014; 20: 345–353.

    Article  CAS  PubMed  Google Scholar 

  27. Andreani M, Testi M, Battarra M, Indigeno P, Guagnano A, Polchi P et al. Relationship between mixed chimerism and rejection after bone marrow transplantation in thalassaemia. Blood Transfus 2008; 6: 143–149.

    PubMed  PubMed Central  Google Scholar 

  28. Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet 2014; 383: 436–448.

    Article  CAS  PubMed  Google Scholar 

  29. Giralt S . Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years? Hematology Am Soc Hematol Educ Prog 2005, 384–389.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all participating EBMT centres for providing data for this survey and Arnaud Dalissier and Sarah Lyon-Caen for their important support.

Author information

Authors and Affiliations

  1. St Anna Children’s Hospital, SCT Unit, Medical University Vienna, Vienna, Austria

    A Lawitschka & C Peters

  2. Department of Haematology-Oncology, Bone Marrow Transplantation Unit, G. Gaslini Children’s Research Institute, Genova, Italy

    M Faraci

  3. Department of Paediatric Haematology Oncology and BMT Unit, Schneider Children’s Medical Center of Israel, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

    I Yaniv

  4. Department of BMT, Great Ormond Street Hospital for Children NHS Trust, London, UK

    P Veys

  5. Division for Stem Cell Transplantation, University Children's Hospital, Frankfurt/Main, Germany

    P Bader

  6. Department of Paediatric Oncology, Haematology and Transplantology, University of Medical Sciences, Poznañ, Poland

    J Wachowiak

  7. Service d'Hematologie-Greffe de Moelle, Hopital Saint Louis, Paris, France

    G Socie

  8. HSCT Program, Oncology, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    M D Aljurf

  9. Department of Haematology, Ankara University Faculty of Medicine, Ankara, Turkey

    M Arat

  10. University Medical Center Utrecht, Paediatric Blood and Marrow Transplantation Program, Utrecht, The Netherlands

    J J Boelens

  11. Department of Haematology, ICO–Hospital Duran i Reynals, Barcelona, Spain

    R Duarte

  12. Department of Haematology, University Hospital Haematology Petersgraben, Basel, Switzerland

    A Tichelli

Authors
  1. A Lawitschka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M Faraci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I Yaniv
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Veys
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P Bader
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J Wachowiak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. G Socie
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M D Aljurf
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M Arat
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. J J Boelens
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. R Duarte
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. A Tichelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. C Peters
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Lawitschka.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lawitschka, A., Faraci, M., Yaniv, I. et al. Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WP. Bone Marrow Transplant 50, 592–597 (2015). https://doi.org/10.1038/bmt.2014.306

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2014.306

This article is cited by

Search

Advanced search

Quick links